Targeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna(Thapar Institute of Engineering & Technology), May Khanna(University of Florida), Lindsey A. Chew(Duke University), Henry M. Colecraft(Columbia University), Samantha Perez‐Miller(University of Arizona), Aude Chefdeville(Apple (Israel)), Shreya S. Bellampalli(Mayo Clinic), Zunaira Shuja(Zhejiang Chinese Medical University), John M. Streicher(University of Arizona), Maria Serafini(University of Arizona), Ki Duk Park(University of Science and Technology), Vijay Gokhale(University of Arizona), Liberty François‐Moutal(UCLouvain Saint-Louis Brussels), Aubin Moutal(Saint Louis University), Shizhen Luo(Apple (Israel)), Jie Yu(Apple (Israel)), Taehwan Ha(Convergence Research Center for Diagnosis Treatment and Care System of Dementia), Xiaofang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Amol Patwardhan(Southwestern Medical Center)
Cited by 44
Related Papers
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
|Frontiers in Neuroendocrinology|2002|485
Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
|Journal of Biological Chemistry|2013|148
MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
|Circulation Research|2010|123
Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity
|Scientific Reports|2021|115